Skip to content

The effect of ostrich oil on musculoskeletal disorders' pain

A Clinical trial to compare the effect of ostrich oil versus placebo on pain in patients with muscluskeletal disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016122831631N1
Enrollment
60
Registered
2017-08-17
Start date
2017-07-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal pain. Myalgia

Interventions

Intervention 1: Intervention group: Each patient will receive a packet and a brochure containing the instructions. Patients will be asked to spray the topical medication(ostrich oil) on the skin twice
Treatment - Drugs
Placebo
Intervention group: Each patient will receive a packet and a brochure containing the instructions. Patients will be asked to spray the topical medication(ostrich oil) on the skin twice per day and ma
Control group: Each patient will receive a packet and a brochure containing the instruction. Patients will be asked to spray the topical medication(olive oil) on the skin twice per day and massage it

Sponsors

Prolife Company
Lead Sponsor
Vice Chancellor for research of Mashhad University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being an adult and having musculoskeletal pain; Having no medical history of injection, surgery and topical medicine on the area. Exclusion criteria: No willingness for participation; Requiring to use brace or cast; Having other conditions such as CTS; Requiring physical therapy; Having history of surgery on the area .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Before intervention, and 1 week(5-10 days), 2 weeks(10-16 days), one month(4-6 weeks) after intervention. Method of measurement: VAS and McGill questionnaire.

Secondary

MeasureTime frame
Symptoms improvement time. Timepoint: At the begining and at the end of the trial. Method of measurement: VAS and McGill questionnaire.;Area of pain. Timepoint: Before and after the intervention. Method of measurement: using the "area of pain" diagram and software for calculating the area.;Quality of Life. Timepoint: Before and after intervention. Method of measurement: WHOQOL questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloufar Alavi

Orthopedic research center

alavi.niloofar@gmail.com+98 51 3841 7453

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026